To evaluate the efficacy of Kalmegh Navayas Tablet in the management of Anemia.

A single arm clinical study to evaluate the efficacy of Kalmegh Navayas in the management of Pandu Roga (IRON DEFICIENCY ANEMIA)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050929

Enrollment

Registered

2023-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Hb level 7 to 10.8 gm/dl. Patients having sign & symptoms of Pandu Roga like Agnimandya, Daurbalya, Aruchi, Twaka vaivarnata, Shoth bhram, Gatrashool ,Shwas kashtata.

Exclusion criteria

Exclusion criteria: a) Pregnant and lactating women. b) Patients with K/C/O Thalassemia, Hereditary Sickle Cell Anemia, Sideroblastic Anemia, Anemia due to any Malignancies, Congenital absence of Iron Binding Protein, Aplastic Anemia, Haemolytic Anemia, etc. c) Patients with menorrhage, metrorrhagia, worm infestation and other bleeding disorders. d) Patients with acute complications like cirrhosis of liver, pancreatitis and Hypoglycemic shock. e) Pandu vyadhi associated with other vyadhi like kamla, halimak.

Design outcomes

Primary

Measure	Time frame
To increase the haemoglobin level in Pandu Roga (Anemia).Timepoint: Follow up of patients on 15 th and 30 th day.	—

Secondary

Measure	Time frame
To observe the adverse effect, if any.Timepoint: Follow up of patients on 15 th and 30 th day.	—

Countries

India

Contacts

Public ContactVd Bhim Gaikwad

Dr. D.Y. Patil College of Ayurved and Research Center

bhimgaikwad60@gmail.com9423003441

Outcome results